HHS issues guidelines expanding access to buprenorphine treatment
Decrease in prostate cancer diagnoses due to pandemic
29 April 2021New York City aims to ‘fully reopen’ on July 1
29 April 2021HHS issues guidelines expanding access to buprenorphine treatment
(HealthDay)—Eligible practitioners who are licensed and registered to prescribe controlled substances are now exempt from certain statutory certification requirements related to training, counseling, and other ancillary services for prescribing buprenorphine, according to guidelines issued by the U.S. Department of Health and Human Services.
